MD1647F1 - Process for clary sage Salvia sclarea plant mass treatment and utilization thereof for treatment of the locomotor apparatus - Google Patents

Process for clary sage Salvia sclarea plant mass treatment and utilization thereof for treatment of the locomotor apparatus

Info

Publication number
MD1647F1
MD1647F1 MD20000070A MD20000070A MD1647F1 MD 1647 F1 MD1647 F1 MD 1647F1 MD 20000070 A MD20000070 A MD 20000070A MD 20000070 A MD20000070 A MD 20000070A MD 1647 F1 MD1647 F1 MD 1647F1
Authority
MD
Moldova
Prior art keywords
treatment
plant mass
utilization
locomotor apparatus
clary sage
Prior art date
Application number
MD20000070A
Other languages
Romanian (ro)
Other versions
MD1647G2 (en
Inventor
Diana Sepeli
Original Assignee
Diana Sepeli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diana Sepeli filed Critical Diana Sepeli
Priority to MDA20000070A priority Critical patent/MD1647G2/en
Publication of MD1647F1 publication Critical patent/MD1647F1/en
Publication of MD1647G2 publication Critical patent/MD1647G2/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Fruits And Vegetables (AREA)

Abstract

The invention refers to the practical medicine and is used for balneologic treatment of the locomotor apparatus. Summary of the invention consists in, that after hydrodistillation of the reduced to fragments clary sage Salvia sclarea plant mass with hot steam it is realized its drying by ventilation at the humidity of no more than 18% and its further reducing to fragments. The obtained plant mass is used for locomotor apparatus treatment.Claims: 2
MDA20000070A 2000-02-15 2000-02-15 Process for clary sage Salvia sclarea plant mass treatment and utilization thereof for treatment of the locomotor apparatus MD1647G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20000070A MD1647G2 (en) 2000-02-15 2000-02-15 Process for clary sage Salvia sclarea plant mass treatment and utilization thereof for treatment of the locomotor apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20000070A MD1647G2 (en) 2000-02-15 2000-02-15 Process for clary sage Salvia sclarea plant mass treatment and utilization thereof for treatment of the locomotor apparatus

Publications (2)

Publication Number Publication Date
MD1647F1 true MD1647F1 (en) 2001-04-30
MD1647G2 MD1647G2 (en) 2001-11-30

Family

ID=19739581

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20000070A MD1647G2 (en) 2000-02-15 2000-02-15 Process for clary sage Salvia sclarea plant mass treatment and utilization thereof for treatment of the locomotor apparatus

Country Status (1)

Country Link
MD (1) MD1647G2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD20010346A (en) * 2001-08-17 2003-06-30 Феликс ШЕПЕЛЬ Process for treatment of the sclary sage (Salvia sclarea) vegetal mass and application thereof in the treatment of locomotorium diseases
MD20010345A (en) * 2001-08-17 2003-06-30 Феликс ШЕПЕЛЬ Process for processing of the clary sage Salvia sclarea vegetal mass and application thereof in the treatment of the locomotor apparatus

Also Published As

Publication number Publication date
MD1647G2 (en) 2001-11-30

Similar Documents

Publication Publication Date Title
BR9906287A (en) Bacterium belonging to the genus escherichia and which has a capacity to produce a l-amino acid, and, process to produce a l-amino acid
NO982172L (en) Use of epinastine for the treatment of pain
BR9803500A (en) Waste treatment method and apparatus.
BR9908256A (en) Use of extracts obtained from iridaceae and racemous cimicifuga and tectorigenin as an estrogen-type organoselective drug without uterotropic effect
NO20025321L (en) Fractionation and processing of oilseed powder
ES2121404T3 (en) PROCEDURE FOR THE PREPARATION OF TRIHYDRATE OF (2R, 3S) -3-TERC-BUTOXICARBONILAMINO-2-HIDROXI-3-FENILPROPIONATO DE 4-ACETOXI-2ALFA-BENZOILOXI-5BETA, 20-EPOXI-1,7BETA-10BETA, 10 -OXO-TAX-11-EN-13ALFA-ILO.
BR9502707A (en) Compound pharmaceutical composition and method for treating a condition
EE05419B1 (en) Substituted oxazolidinones for combination therapy
ES2189768T3 (en) REGIONAL ELEMENTARY SYNTHESIS OF RAPAMYCIN DERIVATIVES.
HUP9903906A2 (en) Use of chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
PL2211884T3 (en) Hydrolysates made of plant extracts and antibacterial agent containing the same
MXPA02004933A (en) Cosmetic compositions containing chick pea extract and retinoids.
UA32542C2 (en) method and device for continuous moistening of friable foodstuffs and fodders
MY128741A (en) Method for the treatment of tobacco
KR880003620A (en) Therapeutic Composition and Method
DE60115031D1 (en) SPERMATOPHYTE PLANT EXTRACTS WITH ANTITUMORAL EFFECT
FR2835438B1 (en) PROCESS AND PLANT FOR THE PRODUCTION OF BREATHABLE AIR
RS50148B (en) Use of docetaxel for treating hepatocellular carcinoma
TR200100637T2 (en) New natural product derivatives
MD1647F1 (en) Process for clary sage Salvia sclarea plant mass treatment and utilization thereof for treatment of the locomotor apparatus
NO20013787L (en) Soybean extract containing lipids, process for its preparation and pharmaceutical and cosmetic compositions
MXPA03011622A (en) Use of glycoprotein for the treatment and re-epithelialisation of wounds.
FR2786394B1 (en) WALNUT COWDER EXTRACT, COSMETIC COMPOSITION COMPRISING SAID EXTRACT AND APPLICATIONS
MD20010345A (en) Process for processing of the clary sage Salvia sclarea vegetal mass and application thereof in the treatment of the locomotor apparatus
MD20010346A (en) Process for treatment of the sclary sage (Salvia sclarea) vegetal mass and application thereof in the treatment of locomotorium diseases

Legal Events

Date Code Title Description
MM4A Patent for invention definitely lapsed due to non-payment of fees